Specifically, DAPA can inhibit hyperglycemia-induced upregulation of intercellular adhesion molecule-1 (ICAM-1), while EMPA inhibits certain chemokines such as monocyte chemoattractant protein-1 (MCP-1). This evidence concerns the gene ICAM1 and Hyperglycemia.